Cargando…

High-Density Mapping in Ventricular Tachycardia Ablation: A PentaRay(®) Study

BACKGROUND: High-density mapping of ventricular tachycardia (VT) with PentaRay(®) (Biosense-Webster) provides high resolution with discrimination of local abnormal electrograms and slow conducting channels. We evaluate the feasibility of PentaRay(®) to characterize the anatomical substrate and assum...

Descripción completa

Detalles Bibliográficos
Autores principales: Maagh, Petra, Christoph, Arnd, Dopp, Henning, Mueller, Markus Sebastian, Plehn, Gunnar, Meissner, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755661/
https://www.ncbi.nlm.nih.gov/pubmed/29317972
http://dx.doi.org/10.14740/cr636w
Descripción
Sumario:BACKGROUND: High-density mapping of ventricular tachycardia (VT) with PentaRay(®) (Biosense-Webster) provides high resolution with discrimination of local abnormal electrograms and slow conducting channels. We evaluate the feasibility of PentaRay(®) to characterize the anatomical substrate and assume an influence of the outcome despite limitations. METHODS: Over a 24-month period, 26 endocardial and four epicardial maps were obtained of 26 VT patients (18 ischemic cardiomyopathy (ICM, 69.2%) and 8 non-ischemic cardiomyopathy (NICM, 30.8%), age 65 ± 9 years). Catheter ablation (CA) was performed with the aim of transecting the isthmus. The endpoint was non-inducibility of any VT. Manual review of the maps was performed and focused on evaluating scarring, bipolar electrograms, and procedure times. RESULTS: In 55.6 ± 34.4 min, 1,085.9 ± 726.2 points were created. The mean ablation time was 50.8 ± 30.1 min. The endpoint was achieved in 12 patients (46.2%). The mean dense scar area and the mean patchy scar area were 49.4 ± 51.8 cm(2) (range 0 - 190 cm(2)) and 14.7 ± 14.9 cm(2) (range 0 - 110 cm(2)), respectively. Analyzing the learning curve, we found a tendency in decreasing procedure times. During the course of follow-up treatment averaging a 14-month period, device interrogation showed that 17 patients (65.4%) had remained free of any arrhythmia recurrence. CONCLUSION: The high-density maps with PentaRay(®) were safely created in a short period of time. Our manual review of the maps reveals limitations of current annotation criteria; nevertheless, medium-term outcomes were encouraging. Further prospective studies are required to validate our findings in a larger cohort of patients.